0001209191-23-005252.txt : 20230127 0001209191-23-005252.hdr.sgml : 20230127 20230127162641 ACCESSION NUMBER: 0001209191-23-005252 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230125 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Betz Stephen F. CENTRAL INDEX KEY: 0001886575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 23563287 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD STREET 2: BUILDING 2 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263744114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-450-6464 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-25 0 0001658247 Crinetics Pharmaceuticals, Inc. CRNX 0001886575 Betz Stephen F. C/O CRINETICS PHARMACEUTICALS, INC. 10222 BARNES CANYON ROAD, BLDG 2 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2023-01-25 4 S 0 8336 21.07 D 67815 D The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $21.07 per share. The range of sales prices on the transaction date was $21.00 to $21.08 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. /s/ Marc Wilson, as attorney-in-fact 2023-01-27